对帕金森病的慢性自适应性深度大脑刺激:临床结果和编程策略
Johannes L Busch1, Jonathan Kaplan1, Jennifer K Behnke1,2
1Department of Neurology, Movement Disorders and Neuromodulation Unit, Charité - Universitätsmedizin Berlin, Berlin, Germany.
NPJ Parkinson's disease
|August 29, 2025
概括
适应性深度大脑刺激 (DBS) 改善了帕金森病患者的幸福感. 这项研究探讨了适应性DBS编程和运动波动的好处.
科学领域:
- 神经科学
- 神经学
- 生物医学工程
背景情况:
- 尽管持续进行深度大脑刺激,但帕金森病 (PD) 往往会导致残留的运动波动.
- 根据实时神经生理反调整刺激的自适应性DBS可以改善PD管理.
- 了解适应性DBS的临床益处和最佳编程对于患者护理至关重要.
研究的目的:
- 评估适应性DBS与持续性DBS在帕金森病患者中的临床益处.
- 探索与实施适应性DBS相关的编程策略和挑战.
- 评估患者对适应性与持续性DBS的偏好.
主要方法:
- 八名帕金森病患者接受了双门自适应DBS,使用底β功率进行编程.
- 在两个星期的适应性和连续性DBS中,使用生态瞬间评估来评估症状的严重程度.
- 收集了患者报告的结果和偏好,患者知道刺激模式.
主要成果:
- 组级分析显示,适应性DBS的整体幸福感显著改善 (p=0. 007).
- 在适应性DBS中观察到增强一般运动的非显著趋势 (p=0. 058).
- 在8名患者中,有3名患者表现出体内健康和运动的显著改善;有6名患者更喜欢适应性DBS.
结论:
- 适应性DBS为经历持续运动症状的选择性帕金森病患者提供了潜在的治疗选择.
- 确定了规划方面的挑战,并提出了有针对性的策略,以促进临床实施.
- 建议采用三步编程方法来指导适应性DBS的临床使用.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.9K
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.4K
相关概念视频
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
